Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perospirone real-world study in schizophrenia
ChiCTR2200063355Phase 4Recruiting
- Sponsor
- Peking University Sixth Hospital
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of perospirone in schizophrenia, sponsored by Peking University Sixth Hospital. Primary endpoints: Schizophrenia Quality of Life Scale and Brief Psychiatric Rating Scale. Started Jul 2022; status: recruiting.
02
Drugs
perospirone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on ChiCTR2200063355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063355.